Kiniksa Pharmaceuticals International, plc
KNSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001730430
In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.
Superinvestors holding KNSA, Q2 2026
No superinvestor reported holding KNSA in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of KNSA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2024
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−49.7%)
Q2 2024
1 superinvestor holding at quarter end
- Added
- HHLR Advisors (Hillhouse) (+0.3%)
Q1 2024
1 superinvestor holding at quarter end
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−31.4%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−61.2%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−10.1%)